NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $25.28 +0.63 (+2.54%) As of 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Astrana Health Stock (NASDAQ:ASTH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Astrana Health alerts:Sign Up Key Stats Today's Range$24.64▼$25.8050-Day Range$24.00▼$33.4452-Week Range$23.12▼$63.20Volume97,212 shsAverage Volume296,301 shsMarket Capitalization$1.42 billionP/E Ratio34.99Dividend YieldN/APrice Target$53.29Consensus RatingModerate Buy Company Overview Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California. Read More Astrana Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks62nd Percentile Overall ScoreASTH MarketRank™: Astrana Health scored higher than 62% of companies evaluated by MarketBeat, and ranked 495th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageAstrana Health has received no research coverage in the past 90 days.Read more about Astrana Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth22.61% Earnings GrowthEarnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 34.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.50.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 34.60, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.57.Price to Earnings Growth RatioAstrana Health has a PEG Ratio of 1.35. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 1.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.96% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Astrana Health has recently increased by 2.08%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.96% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Astrana Health has recently increased by 2.08%, indicating that investor sentiment is decreasing. News and Social Media2.4 / 5News Sentiment0.36 News SentimentAstrana Health has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Astrana Health this week, compared to 5 articles on an average week.Search Interest6 people have searched for ASTH on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by Insiders20.00% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Email Address ASTH Stock News HeadlinesAstrana Health Announces Closing of Prospect Health AcquisitionJuly 2 at 7:00 AM | prnewswire.com5 Must-Read Analyst Questions From Astrana Health’s Q1 Earnings CallJune 30 at 5:49 PM | msn.comBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.July 3 at 2:00 AM | Crypto 101 Media (Ad)Astrana Health Inc. (ASTH) Stock Price Today - WSJJune 28, 2025 | wsj.com2 Healthcare Stocks with Competitive Advantages and 1 to Keep Off Your RadarJune 26, 2025 | msn.comAstrana Health Approves 2024 Equity Incentive PlanJune 11, 2025 | tipranks.comAstrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for AllJune 3, 2025 | prnewswire.comAstrana Health, Inc. to Participate in Upcoming Investor ConferenceJune 2, 2025 | prnewswire.comSee More Headlines ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $31.53 on January 1st, 2025. Since then, ASTH stock has decreased by 20.8% and is now trading at $24.97. View the best growth stocks for 2025 here. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) issued its quarterly earnings results on Thursday, May, 8th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.09. The company's revenue was up 53.4% compared to the same quarter last year. Read the conference call transcript. How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Astrana Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings5/08/2025Today7/03/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryBusiness Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CIK1083446 Webwww.apollomed.net Phone626-282-0288Fax818-839-5190Employees1,900Year FoundedN/APrice Target and Rating Average Stock Price Target$53.29 High Stock Price Target$70.00 Low Stock Price Target$36.00 Potential Upside/Downside+116.2%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$0.72 Trailing P/E Ratio34.24 Forward P/E Ratio21.43 P/E Growth1.35Net Income$43.15 million Net Margins1.56% Pretax Margin2.95% Return on Equity4.90% Return on Assets2.68% Debt Debt-to-Equity Ratio0.54 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$2.03 billion Price / Sales0.68 Cash Flow$1.46 per share Price / Cash Flow16.89 Book Value$14.59 per share Price / Book1.69Miscellaneous Outstanding Shares56,060,000Free Float44,850,000Market Cap$1.38 billion OptionableOptionable Beta0.84 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:ASTH) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.